Krystal Biotech

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell KRYS and other ETFs, options, and stocks.

About KRYS

Krystal Biotech, Inc. operates as a biotechnology company, which engages in discovery, development, manufacturing, and commercialization of pharmaceutical products. It offers the product, VYJUVEK. 

CEO
Krish S. Krishnan
CEOKrish S. Krishnan
Employees
295
Employees295
Headquarters
Pittsburgh, Pennsylvania
HeadquartersPittsburgh, Pennsylvania
Founded
2016
Founded2016
Employees
295
Employees295

KRYS Key Statistics

Market cap
9.15B
Market cap9.15B
Price-Earnings ratio
45.60
Price-Earnings ratio45.60
Dividend yield
Dividend yield
Average volume
837.07K
Average volume837.07K
High today
$341.11
High today$341.11
Low today
$303.04
Low today$303.04
Open price
$320.70
Open price$320.70
Volume
404.21K
Volume404.21K
52 Week high
$382.54
52 Week high$382.54
52 Week low
$130.50
52 Week low$130.50

Stock Snapshot

The current Krystal Biotech(KRYS) stock price is $308.49, with a market capitalization of 9.15B. The stock trades at a price-to-earnings (P/E) ratio of 45.60.

As of 2026-08-03, Krystal Biotech(KRYS) stock has fluctuated between $303.04 and $341.11. The current price stands at $308.49, placing the stock +1.8% above today's low and -9.6% off the high.

Krystal Biotech(KRYS) shares are trading with a volume of 404.21K, against a daily average of 837.07K.

In the last year, Krystal Biotech(KRYS) shares hit a 52-week high of $382.54 and a 52-week low of $130.50.

In the last year, Krystal Biotech(KRYS) shares hit a 52-week high of $382.54 and a 52-week low of $130.50.

KRYS News

TipRanks 4h
Krystal Biotech reports Q2 EPS $1.79, consensus $1.91

Reports Q2 revenue $119.22M, consensus $121.04M. “Our second quarter reflects the strength of the Krystal model: a global commercial product that continues to p...

Nasdaq 5h
Krystal Biotech, Inc. Q2 Profit Climbs

(RTTNews) - Krystal Biotech, Inc. (KRYS) released earnings for its second quarter that Increased, from the same period last year The company's bottom line came...

Krystal Biotech, Inc. Q2 Profit Climbs
Simply Wall St 2d
Does KB801’s Single-Patient Signal And S&P 400 Move Change The Bull Case For Krystal Biotech? - simplywall.st

...

Does KB801’s Single-Patient Signal And S&P 400 Move Change The Bull Case For Krystal Biotech? - simplywall.st

Analyst ratings

92%

of 12 ratings
Buy
91.7%
Hold
8.3%
Sell
0%

More KRYS News

Simply Wall St 4d
US High Growth Tech Stocks To Watch In July 2026

Over the last 7 days, the United States market has experienced a 2.6% drop, yet it remains up by 14% over the past year with earnings forecasted to grow by 17%...

US High Growth Tech Stocks To Watch In July 2026

People also own

Based on the portfolios of people who own KRYS. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.